Beam Therapeutics (BEAM) Stock
Beam Therapeutics (BEAM) closed at $20.65 on Nov 17, 2026; its Tenet Score is 61 of 100 against 340 Healthcare peers.
23 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $20.65
- Nov 17, 2026
- Market cap
- $2.2B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 20.23 – 38.26
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 61/100
- Solid · 340 Healthcare peers
Industry: Drugs
Beam Therapeutics Inc scores 61/100. Solid. Strongest on financial health and value, quality is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 61 is built from 3 of 4 pillars, from 50% of its inputs. Growth is left out because no growth rate could be measured.
Tenet Score · vs sector
n=340Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
13F flows & insider trades land here.
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-1…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Neogen Corp.NEOG | 45 | $2.4B |
| Regencell Bioscience Holdings LtdRGC | 31 | $2.3B |
| NewAmsterdam Pharma Company NVNAMS | 58 | $2.3B |
| Lakefront Biotherapeutics NVLKFT | 82 | $2.3B |
| Perrigo Company plcPRGO | 40 | $2.3B |
| Celldex Therapeutics Inc.CLDX | 44 | $2.2B |
| Immunome IncIMNM | 49 | $2.1B |
| Aurinia Pharmaceuticals IncAUPH | 82 | $2.1B |
| Schrodinger IncSDGR | 41 | $2.1B |
| Vera Therapeutics IncVERA | 41 | $1.9B |
Common questions
What sector and industry is Beam Therapeutics in?
Beam Therapeutics is in the Healthcare sector and the Drugs industry.
What is Beam Therapeutics' Tenet Score?
Beam Therapeutics' Tenet Score is 61 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




